Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.91 USD | -7.50% | -6.87% | -21.03% |
Jun. 05 | Morgan Stanley Adjusts COMPASS Pathways Price Target to $23 From $30, Maintains Overweight Rating | MT |
Jun. 04 | FDA panel to review psychedelic drug MDMA for first time | RE |
Evolution of the average Target Price on COMPASS Pathways plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering COMPASS Pathways plc
Morgan Stanley | |
Deutsche Bank Securities | |
Canaccord Genuity | |
Citigroup | |
EF Hutton | |
Oppenheimer | |
Berenberg Bank | |
Loop Capital | |
HC Wainwright | |
Cantor Fitzgerald | |
Roth Capital Partners | |
Maxim | |
BTIG |
EPS Revisions
- Stock Market
- Equities
- CMPS Stock
- Consensus COMPASS Pathways plc